drugset / Trial / NCT04166838
The Clinical Study of CD19 UCAR-T Cells in Patients With B-cell Acute Lymphoblastic Leukemia (B-ALL)
NaSingle-groupOpen-labelTreatment
Summary
This is a single arm, open-label, single center, exploratory clinical study to evaluate the safety and efficacy of CD19 UCAR-T Cells in Patients With CD19+ B-cell acute lymphoblastic leukemia (B-ALL).
Timeline
- Start
- 2019-11-08
- Primary completion
- 2019-11-08
- Completion
- 2019-11-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CD19 UCARTcells | Cell therapy | 1e+06 cells/kg | Other |
| Subject | CD19 UCARTcells | Cell therapy | 3e+06 cells/kg | Other |
| Subject | CD19 UCARTcells | Cell therapy | 5e+06 cells/kg | Other |